Barium enema: does splitting the buscopan dose reduce patient discomfort, whilst maintaining image quality?
- Disease/Condition
- Procedure
- Drug/Device/Intervention
- Barium
- Study type
- Interventional
- Intervention type
- drug
- Primary sponsor
- Department of Health
- Funder
- South Manchester University Hospitals NHS Trust (UK)
- Location
- United Kingdom
- Phase
- Not Applicable
- Start date
- Sep 01, 2003
- End date
- Jun 01, 2005
- Enrollment
- 200 participants
To investigate if splitting the 20 mg of Buscopan (hyoscine-butylbromide) into two doses of 10 mg each, with one dose being administered at the usual point in the examination, and the second dose being administered just before the final images are obtained, will decrease patient discomfort, with no loss of image quality.
- Registry
- ISRCTN Registry
- Trial ID
- ISRCTN32878249
- Type
- Non-Device Trial
Access comprehensive clinical trial information for ISRCTN32878249 through Pure Global AI's free database. This Not Applicable trial is sponsored by Department of Health and is currently status unknown. The study focuses on Procedure. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.